STOCK TITAN

[6-K] InflaRx N.V. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2025

 

Commission File Number: 001-38283

 

 

 

InflaRx N.V.
(Translation of registrant's name into English)

 

 

 

Winzerlaer Str. 2
07745 Jena, Germany

(Address of principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F Form 40-F

 

 

 

 

 

 

EXPLANATORY NOTE

 

Exhibits 99.1 and 99.2 to this report on Form 6-K (the “Report”) shall be deemed to be incorporated by reference into (i) the registration statements on Form S-8 (File No. 333-221656 and 333-240185) and (ii) the registration statement on Form F-3 (File No. 333-273058) of InflaRx N.V. and to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

Exhibit 99.3 to this Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   InflaRx N.V. Unaudited Condensed Consolidated Financial Statements as of and for the Six  Months Ended June 30, 2025
99.2   InflaRx N.V. Management’s Discussion and Analysis of Financial Condition and Results of Operations
99.3   InflaRx N.V. Press Release dated August 7, 2025
101.INS   Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INFLARX N.V.
Date: August 7, 2025 By: /s/ Niels Riedemann
  Name:  Niels Riedemann
  Title: Chief Executive Officer

 

 

3

 

 

Inflarx

NASDAQ:IFRX

IFRX Rankings

IFRX Latest News

IFRX Latest SEC Filings

IFRX Stock Data

56.91M
63.42M
6.44%
26.33%
1.46%
Biotechnology
Healthcare
Link
Germany
Jena